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Abstract  
Parkinson’s disease is a common neurodegenerative disorder. It is associated with the 
central nervous system that affects movement, it often includes tremors, stiffness, and inability to 
plan and think. Nerve cell damage in the brain causes lower production of dopamine leading to 
those symptoms. There is no cure for Parkinson’s disease, but there are medications that can help 
control the symptoms. Researchers are suggesting that dysbiosis in gut microbiota could lead to 
the development of a protein called alpha synuclein in the intestines, and through intestinal 
leakage, this protein could possibly spread pathologically to the brain by the central nervous 
system. This protein then folds and forms a clump blocking dopamine production and then 
causing symptoms of Parkinson’s disease. What causes this protein to fold is still unknown.  
This review focuses specifically on what factors may be contributing to Parkinson’s disease, the 
effects gut microbiota has on Parkinson’s disease, and how the alpha synuclein protein plays an 
important role in Parkinson’s disease. With all information found, dysbiosis of the intestines 
cannot be concluded to be the cause of Parkinson’s disease.  
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Introduction 
Parkinson’s disease is a neurodegenerative disorder that affects dopamine producing 
neurons in a specific area of the brain that is called substantia nigra. The substantia nigra is 
located in the midbrain and plays an important role in movement, reward, and addiction. Its 
function is to control dopamine production and it consist of two parts, the pars compacta and 
pars reticulata. The pars compacta contain neurons colored in black by pigment neuromelanin, 
and the pars reticulata is where the dendrites function. In Parkinson’s patients, the substantia 
nigra will cause balance problems, tremors, limb rigidity, and thinking/solving problems. 
Although this disease is not fatal, it is serious and has serious effects on the quality of life.  
About 7 to 10 million people worldwide live with Parkinson’s diseases and about 4 percent of 
people with Parkinson’s disease are diagnosed before the age of 50. Men are 1.5 times more 
likely to get Parkinson’s disease than women. In the U.S alone, the overall cost of Parkinson’s 
disease including treatments, loss of income, and social security are estimated to be $25 billion 
per year (parkinsons.org). However, despite the research that has been done on Parkinson’s, the 
cause is still unknown. Microbes in the gut microbiota have impacts on how disease will affect 
the body. In this study, there will be a focus on the effects of unbalanced gut microbiota on 
Parkinson’s disease. This is significant because knowing exactly what links gut microbiota and 
Parkinson’s diseases share could possibly predict how likely one is susceptible to the disease. 
This review will focus on exploring the microbiota in patients with Parkinson’s vs patients 
without Parkinson’s, the proteins that are associated with Parkinson’s, and how dysbiosis of the 
gut along with the proteins effect brain stimulation.  
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Understanding What Parkinson’s Disease is and the Associations of Parkinson’s 
Disease 
Parkinson’s disease is a neurological disorder that affects the motor system. Dopamine is 
a chemical transmitter that allows nerve cells to send signals within the brain that allows us to 
control our movements. In a normal human brain, cells produce dopamine that pass signals 
within the brain to produce a movement of a muscle in a smooth form. In Parkinson’s patients, 
80 percent, and sometimes even more of the cells that produce dopamine are either dead, 
damaged or somehow degenerated. This will cause the cells to fire uncontrollably within the 
brain not allowing patients to control their movements. Symptoms of this would-be things such 
as tremors in the legs, arms, and hands. Also, stiffness, impaired coordination, balance problems, 
and slowness of movements.  
Research done in Parkinson’s disease has found that genetics plays a big role in this disease. 
There are five genes that are thought to play a role in this disease, Parkin, SCA2, Alpha 
synuclein, Ubiquitin carboxyl-terminal hydrolase, and DJ-1. Within these genes, it is their 
mutations which have been found to be the underlying cause (Gerhard, 2018). Researchers 
believe that environmental factors act on these specific genes which then lead to Parkinson’s 
disease. If this mechanism can be figured out, we could possibly then disrupt it and stop it from 
leading to Parkinson’s disease. One of the environmental factors and/or mechanisms researchers 
think it may be is the link of gut microbiota and the brain of Parkinson’s disease patients.  
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The Dysbiosis of Gut Microbiota 
Dysbiosis of the gut is a term used to describe the microbial imbalance of the human intestines. 
The human gut contains trillions of microorganisms of which include more than 1000 different 
species of bacteria. While we all have our own unique structure of microbiota, it physiologically 
impacts our health in the same ways. The gut microbiota is a composed community of 
microorganism inhibiting the gastrointestinal track. The composition of the microbes is host 
specific. Mammals gut microbiota can undergo alterations, all mammals are born with a sterile 
gastrointestinal tract and then are developed within the first years of life. In the first year of life 
especially, the gut microbiota will change through interactions with the developing immune 
system. Different environmental factors will also determine the composition of the gut 
microbiota and will have a potential to be a main determiner in life long health. The balance of 
gut microbiota can be affected as we age and the imbalance of microbiota is something we call 
dysbiosis. Dysbiosis can be linked to many health problems such as bowel disease, obesity, and 
now even Parkinson’s disease. Differences in the gut microbiota can result in changes of 
substances within the gut and intestinal permeability which can influence the central nervous 
system. 
 It has been considered that bacteria can enhance inflammatory response and that the imbalance 
of gut dysbiosis can disrupt the blood-brain barrier and increase neuro-inflammation. (Jankovic, 
2018). It has been shown that many Parkinson’s patients have a reduced number of 
Prevotellaceae family and an increased number of Enterobacteriaceae. The shift associated with 
these two bacterial families shows a decrease in mucin synthesis and increase in intestinal 
permeability, this is consistent with inflammatory pathways and protein miss-folding (Jankovic, 
2018). Gut bacteria are able to control the differentiation and function of the immune cells in the 
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intestine and brain. Typically, patients with Parkinson’s disease experience intestinal 
inflammation such as constipation and many years later is followed by motor defects. 
 
What Different Factors Affect the Composition of Gut Microbiota 
In a conducted case study (Keshavarzian, 2011) there were 13 taxa, 8 genera, and 7 families that 
were associated with Parkinson’s disease. A few of those were only potentially confounded, but 
most were robust. Deletion of chain fatty acids in Parkinson’s disease was also found. Chain 
fatty acids are made by bacteria in the gut, such as Lachnospiraceae. Lachnospiraceae was 
shown to have reduced levels in those patients with Parkinson’s disease (Jankovic, 2018). This is 
suggesting Parkinson’s patients have unbalanced dysbiosis of the gut.  
This study (Keshavarzian, 2011) also suggests that there may be an increase in activity of 
Parkinson’s in pathways that degrade xenobiotics (substances foreign to the body), atrazine 
(herbicide), and a few others. According to the U.S Environmental Protection Agency, atrazine is 
the most common herbicide contaminant in ground water found here in America. This is 
important because exposure to this herbicide by drinking water or by elsewhere is known to 
increase the risk of developing Parkinson’s disease in animal models. This suggest that 
herbicides could also play a role in gut microbiota. If atrazine found in ground water that people 
drink is known to increase the risk of developing Parkinson’s in animal models, then it should be 
a serious concern for humans as well. 
A study conducted (Gerhard, 2018) used gut bacteria from Parkinson’s patients and healthy 
controls to transplant fecal matter into genetically susceptible mice. The mice with gut bacteria 
from the Parkinson’s patient revealed enhanced motor impairment compared to the microbiota 
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from the healthy controls. This suggests that certain microbes from the Parkinson’s patients 
holds disease-like symptoms unlike the healthy controls that were used.  
 
Possible Causes of Dysbiosis  
Supporting evidence suggests that there is a link between dysbiosis of gut microbiota and 
Parkinson’s disease. But what is the cause of dysbiosis? Epidemiological evidence shows 
pesticide exposure to Parkinson’s disease with some specific pesticides being known to impact 
gut microbiota. Parkinson’s patients may be missing or have a reduced number of protective 
microbes in their microbiota causing dysbiosis to result in differential production of microbial 
molecules (Keshavarzian, 2011).  
Other researchers propose that physical and psychological stress, dietary factors, and antibiotics 
all contribute to intestinal dysbiosis. A study conducted shows that exposure to psychological 
stress results in lower production of mucin and acidic mucopolysaccharides on the mucosal 
surface of the intestines. Because mucopolysaccharides and mucin are both needed for inhibiting 
adherence of pathogenic microorganisms to intestines mucosa, a decrease in either will 
contribute to colonization by pathogenic microorganisms (Hawrelak, 2004). A well-balanced diet 
will benefit people by assisting with the growth of more beneficial microorganisms, while some 
other diets with assist gut microbiota activity that can be harmful to the host. Lastly, antibiotics 
are the most significant cause of dysbiosis of the intestines. Antimicrobial agents will influence 
dysbiosis of the intestine by its spectrum of activity, dosage and length of time taken. Depending 
on all of these factors will tell how much dysbiosis is happening and how dysbiosis starts 
affecting molecules and gut barriers (Hawrelak, 2004). 
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When dysbiosis has occurred, molecules start getting altered and the functions of gut barriers and 
intestinal permeability changes. The rearranged microbiota products inside the intestines, such as 
proteins may leave the intestines and travel to brain via central nervous system. Alpha synuclein, 
a protein that is a neuropathological hallmark of Parkinson’s disease may appear in the gut 
before it appears in the brain because of dysbiosis. These observations may have led to the 
assumptions that Parkinson’s disease starts in the gut and then spreads to the brain by a leaky gut 
membrane (Pereira, 2018).  
 
Effects of Increased Intestinal Permeability  
Intestinal permeability is a term used to describe the ability of substances such as bacteria 
and proteins to pass through the gut and into the body by cells that line the gut wall. Once 
substances are released through the gut they can travel to the brain by the central nervous system.  
A study conducted (Forsyth, 2011) tested to see if Parkinson’s patients show increased intestinal 
permeability to microbes in the intestines. This was done by assessing the permeability of the gut 
with Parkinson’s patients and healthy controls. Intestinal biopsies of both groups were taken and 
the bacterial translocation and the protein alpha synuclein were both observed. Intestinal hyper 
permeability was found to significantly correlate with E. coli bacteria and alpha synuclein 
protein in the Parkinson’s patients. This suggests that the Parkinson’s patients do in fact have a 
leaky gut barrier compared to the healthy controls who did not. Once the gut starts leaking 
materials, they can enter into the blood stream and cause widespread inflammation. They can 
also travel to the brain by the central nervous system.  
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  Folding of Alpha Synuclein Protein  
Other research on gut microbiota and the association of Parkinson’s disease show from 
conducted studies (Jankovic, 2018) of fecal samples taken within the duration of two years or 
less, that the count of bacteria is different with Parkinson’s patients and heathy controls, but the 
type of bacteria specifically is almost the same. There were no different bacteria found that were 
typically more present in one of the study groups. This is suggesting that the type of bacteria 
present within the intestines is not as relevant as the balance that allows enough good bacteria to 
remain present.  
Typically, in previous studies, the healthy controls and the Parkinson’s patient’s intestinal 
bacteria type remained pretty much the same. It was the count that was higher or lower within 
the two groups that was different, with Parkinson’s patients having more dysbiosis then the 
healthy controls. What seems to be present in most case studies is the alpha synuclein protein in 
association with intestinal permeability. Alpha synuclein is a protein found in the human body. 
Within the brain, it is specifically found at the end of nerve cells (those which send signals 
throughout the brain allowing movement) which are responsible for releasing chemicals such a 
dopamine. Dopamine is the neurotransmitter that is involved with the control of voluntary and 
involuntary movements. These alpha synuclein proteins in a Parkinson’s patients are 
hypothesized to form and leak out of the intestines because of dysbiosis and intestinal 
permeability, travel up to the brain via central nervous system, and form a sort of clump that is 
toxic at the end of nerve cells that release dopamine. This folded alpha synuclein protein will 
block the ability of dopamine to release and can even lead to cell death. Because dopamine is 
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unable to release, patients with Parkinson’s cannot control voluntary and involuntary movements 
with the blockage of this protein inside the brain. What causes this protein to fold and is still 
unknown and is being studied.  
 
Promoting Good Intestinal Health 
Making sure there is not increase in intestinal permeability is more crucial than people may 
think. Leaky gut walls are usually caused by the type of diet that one is consuming. Diets that 
consume of a lot of grain, wheat, sugar, processed meats, and oils are those more susceptible to 
have increase intestinal permeability (healthline.com). Other factors play a role in increased 
intestinal permeability also, such as nonsteroidal anti-inflammatory drugs which include 
Acetaminophen, Tylenol, and Ibuprofen. Taking rounds of antibiotics and chronically being 
stressed has also been known to cause leaky intestines.  
Symptoms of increased intestinal permeability may be constipation, diarrhea, bloating, excessive 
burping and gas, migraines, weight gain, autoimmune conditions, fatigue and food allergies 
(healthline.com). There is testing that can be done to determine if one is having increased 
intestinal permeability. Those tests would include bacterial dysbiosis test, blood tests checking 
for IgG and IgA antibodies produced by the immune system, a comprehensive stool and 
digestive analysis test (healthline.com). Increased intestinal permeability develops slowly over 
years, and healing the gut also takes time. It can take anywhere from three months to a year by 
eating healthier, taking probiotics, and keeping stress levels under control to repair a leaky gut.  
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Conclusion 
While we all have our own unique structure of microbiota, it physiologically impacts our 
health in the same ways. The balance of our gut microbiota can be affected as we age by diet, 
drug consumption, environmental factors, and even our genetics. The imbalance of our 
microbiota can have consequences to our health. The research done on gut microbiota with the 
association of Parkinson’s disease shows almost always that the count of bacteria is different 
with Parkinson’s patients vs heathy controls, but the type of bacteria found between the two 
groups is typically the same. While it is unsure if increased intestinal permeability from 
microbiota causes Parkinson’s disease, it is hypothesized that dysbiosis in the intestine might be 
the reason for neuro-inflammation that leads to the alpha synuclein protein folding in patients 
with Parkinson’s. What causes this protein to fold and clump is still unknown. Research is 
suggesting it may start in the dysbiosis of the intestines and then lead to the development of 
intestinal alpha synuclein, and through increased intestinal permeability, it pathologically spreads 
to the brain and folds. Because of this protein folding, nerve cells that send signals throughout 
the brain by releasing chemicals like dopamine are interrupted by the folding of the toxic protein. 
This follows by the symptoms of Parkinson’s disease, such as tremors, stiffness, imbalance, and 
ability to plan and think. In conclusion, this review found out that increased intestinal 
permeability may be the cause of the alpha synuclein protein leaking out of the gut and spreading 
to the brain by the central nervous system. This review also found that dysbiosis of the gut could 
be where the start of Parkinson’s disease occurs many years before diagnosis. Lastly, this review 
found that alpha synuclein plays a very important role in contributing to Parkinson’s disease 
because it blocks dopamine production by folding. With all information found, dysbiosis cannot 
be concluded to be the cause of Parkinson’s disease. As there is no cure for Parkinson’s disease, 
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managing the microbiota would be the most helpful thing to do, yet also very challenging. 
Although a good diet may decrease intestinal permeability, there is no control over genetics, 
environmental factors, pathogens, antibiotics, and immunity.  
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